Economists estimate that, in the coming decades, pandemics will cause average annual economic losses of 0.7% of global GDP – a threat similar in scale to that estimated for climate change. As this report makes clear, this is a level of risk that businesses can no longer afford to ignore.

Aboriginal and Torres Strait Islander communities have some of the highest rates of rheumatic heart disease (RHD) in the world. This report outlines the trajectory of acute rheumatic fever (ARF) and RHD in Australia until 2031, assuming only the current levels of funding and attention to these diseases.

This report paints the clearest picture yet of the true burden of lung cancer in Australia, now and over the next decade. It hones in on the confronting challenges facing those living with lung cancer and outlines solutions to improve outcomes that are currently far from what is possible.

In 2015–16, there were an estimated 18,746 new hip fractures in Australia, a crude rate of 199 hip fractures per 100,000 population aged 45 and over. This represents a decline in the rate of hip fractures over time, suggesting that measures to reduce risk factors and prevent falls are having an effect.

Deloitte Access Economics has prepared this report for Novartis that provides insight into the burden of migraine in Australia.